Mayet Mayet
Product Blog Resources About
Contact Us
  1. Blog
  2. Author: Tom Lazenby
  3. Page 2
  • When Does Oversight Become Overkill?

    Sep 3, 2024

    —

    by

    Tom Lazenby
    in General
    When Does Oversight Become Overkill?

    Managing service providers effectively is critical. Ensuring quality, compliance, and operational efficiency while maximising return on investment (ROI) is critical for Sponsors. However, there is a fine line between effective oversight and micromanagement, where too much oversight can lead to frustration, decreased trust, and ultimately, a breakdown in the relationship between sponsors and service providers.…

    Read more »: When Does Oversight Become Overkill?
  • The Rise of Decentralized Clinical Trials

    Aug 20, 2024

    —

    by

    Tom Lazenby
    in General
    The Rise of Decentralized Clinical Trials

    In what can only be described as my longest blog post yet, I am also providing you with a contents below with links to skip to the sections that interest you the most. Decentralized Clinical Trials (DCTs) offer a new approach that was accelerated by the COVID-19 pandemic. These trials utilise digital tools and local…

    Read more »: The Rise of Decentralized Clinical Trials
  • Exploring the Non-Linear Relationship Between Risk and Complexity in Clinical Trials

    Aug 13, 2024

    —

    by

    Tom Lazenby
    in General
    Exploring the Non-Linear Relationship Between Risk and Complexity in Clinical Trials

    I am writing this blog post as a response to a poll which I ran on LinkedIn recently. The post explored the new challenges in Sponsor Oversight based on the upcoming implementation of ICH GCP E6 R3, based on the current draft we all have access to. As you can see from the results in…

    Read more »: Exploring the Non-Linear Relationship Between Risk and Complexity in Clinical Trials
  • Total Cost Of Risk in Clinical Trial Outsourcing

    Aug 7, 2024

    —

    by

    Tom Lazenby
    in General
    Total Cost Of Risk in Clinical Trial Outsourcing

    Anyone who has met me knows that I love to learn, and when I read about something new that interests me I can disappear down a rabbit hole of research for days. I also repeatedly turn to different industry sectors for inspiration on what I can learn, and how that can be applied to our…

    Read more »: Total Cost Of Risk in Clinical Trial Outsourcing
  • Evolution of Outsourcing in Clinical Trials

    Jul 25, 2024

    —

    by

    Tom Lazenby
    in General
    Evolution of Outsourcing in Clinical Trials

    Since clinical trial outsourcing emerged in the late-20th century, there have been significant shifts in its approach and benefits. Driven by evolving regulatory requirements, technological advancements, and changing business needs, outsourcing in clinical trials has allowed organisations to enhance efficiency and reduce costs. If you already understand outsourcing models in detail, then it is worth…

    Read more »: Evolution of Outsourcing in Clinical Trials
  • Cooking Up Success: The Chef’s Guide to Clinical Vendor Management

    Jun 18, 2024

    —

    by

    Tom Lazenby
    in General
    Cooking Up Success: The Chef’s Guide to Clinical Vendor Management

    This blog post is inspired by an analogy brought up by Terttu Haring from Syneos who was sitting on a panel discussion. Terttu interestingly compared outsourcing strategies and selection of service providers with how we do grocery shopping (I’ll clarify below). This made me think more about the end-to-end process of vendor management and oversight…

    Read more »: Cooking Up Success: The Chef’s Guide to Clinical Vendor Management
  • Avoiding TMF Transfer Disasters: A Sponsor’s Survival Guide

    Jun 5, 2024

    —

    by

    Tom Lazenby
    in General
    Avoiding TMF Transfer Disasters: A Sponsor’s Survival Guide

    TMF Retrieval: What Does This Mean? TMF (Trial Master File) retrieval refers to the process of transferring the complete set of documentation related to a clinical trial from a Contract Research Organisation (CRO) back to the sponsor once the study is complete. This documentation is typically stored in an electronic TMF (eTMF) during the study.…

    Read more »: Avoiding TMF Transfer Disasters: A Sponsor’s Survival Guide
  • What’s In A Name?

    May 24, 2024

    —

    by

    Tom Lazenby
    in General
    What’s In A Name?

    Why is our company name “Mayet”? I have been asked the following question a lot recently at various events and on calls with clients, so I thought it would be best to write it out for everyone. Choosing the right name for a company is an interesting process. For me it was not just a…

    Read more »: What’s In A Name?
  • Managing Underperforming Vendors

    May 8, 2024

    —

    by

    Tom Lazenby
    in General
    Managing Underperforming Vendors

    Ever been in that position where you’ve picked a vendor who looks shiny on paper but ends up failing to deliver on the primary deliverables? You’re deep in the vendor selection process, wading through proposals, and one vendor stands out, shining brighter than the rest. They talk a big game, promising flawless execution. But as…

    Read more »: Managing Underperforming Vendors
  • Vendor Audit Strategy: Perfecting the Process for Peak Performance

    May 1, 2024

    —

    by

    Tom Lazenby
    in General
    Vendor Audit Strategy: Perfecting the Process for Peak Performance

    Effective vendor management through robust auditing strategies is imperative for success. In this blog post I have thought about the critical components and strategic requirements of risk-based and value-based audit strategies. These strategies are crucial for enhancing the efficiency, reliability, and outcome of clinical trials. Understanding how prioritising audit resources, aligning with broader business goals,…

    Read more »: Vendor Audit Strategy: Perfecting the Process for Peak Performance
←Previous Page Next Page→

Search

Topics

  • General

Latest Posts

  • Mayet Goes Modular!
  • Integration Partnership with PHARMASEAL CTMS
  • Mayet Strengthens Quality Leadership with Addition of New Strategic Advisor
  • 8 Transformative ICH E6(R3) Service Provider Management Requirements
  • The Human Side of Clinical Trial Quality
  • Mayet Strengthens Commercial Leadership with Addition New Strategic Advisor
  • Vendor Risk Management: A Modern Approach

Footer

Mayet

Mayet Solutions Ltd
London, W1W 5PF
United Kingdom

Phone: +44 792 012 2927

LinkedIn

Mayet Software

  • Product
  • Request Demo

Resources

  • Briefing
  • Webinar
  • GCP R3 Seminar
  • White Paper
  • Resources

Company

  • Blog
  • Contact
  • About
  • Security & Compliance
  • Legal

© 2023-2024 Mayet Solutions Ltd – All rights reserved

Cyber Essentials Insurance Cyber Essentials Plus Certified